Cargando…
Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
Citrate anticoagulation has risen in interest so it is now a real alternative to heparin in the ICUs practice. Citrate provides a regional anticoagulation virtually restricted to extracorporeal circuit, where it acts by chelating ionized calcium. This issue is particularly true in patients ongoing C...
Autores principales: | Mariano, Filippo, Bergamo, Daniela, Gangemi, Ezio Nicola, Hollo', Zsuzsanna, Stella, Maurizio, Triolo, Giorgio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097066/ https://www.ncbi.nlm.nih.gov/pubmed/21603110 http://dx.doi.org/10.4061/2011/748320 |
Ejemplares similares
-
Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy
por: Mariano, Filippo, et al.
Publicado: (2023) -
Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013) -
Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023) -
Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011) -
Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)